Markets

Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio

Oct 20, 2026 · 08:32 AM ET· updated 54m ago

The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.HINGHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Microbot

Why It Matters

Microbot Medical got approval for new inventions in four countries. This protects their ideas and shows their business is moving forward globally.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

MBOT0.95

-0.00 (-0.49%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.